Showing results (301-310 of 365) with videos related to
Sort By:
Pageof 37
Nature Cell Biology|July 17, 2023
H3K36 methylation maintains cell identity by regulating opposing lineage programmesMichael S Hoetker, Masaki Yagi, Bruno Di Stefano, et al.Nature|August 1, 2014
Clonal evolution in breast cancer revealed by single nucleus genome sequencingYong Wang, Jill Waters, Marco L Leung, et al.Blood Advances|July 6, 2022
In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependenciesFrancois E Mercier, Jiantao Shi, David B Sykes, et al.BMC Cancer|April 18, 2015
DNA copy number analysis of metastatic urothelial carcinoma with comparison to primary tumorsRichard M Bambury, Ami S Bhatt, Markus Riester, et al.Biorxiv : the Preprint Server for Biology|July 9, 2025
PROFET Predicts Continuous Gene Expression Dynamics from scRNA-seq Data to Elucidate Heterogeneity of Cancer Treatment ResponsesYu-Chen Cheng, Hyemin Gu, Thomas O McDonald, et al.Nature Communications|June 18, 2021
Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancerKamrine E Poels, Adam J Schoenfeld, Alex Makhnin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Myeloma Cell Dynamics in Response to Treatment Supports a Model of Hierarchical Differentiation and Clonal EvolutionMin Tang, Rui Zhao, Helgi van de Velde, et al.Nature Genetics|August 25, 2015
In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancerMichalina Janiszewska, Lin Liu, Vanessa Almendro, et al.Cancer Discovery|June 8, 2026
A pan-cancer single-cell analysis of intratumoral copy number diversity and evolutionHanghui Ye, Thomas O McDonald, Reem Elghaish, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 2, 2023
Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung AdenocarcinomasArielle Elkrief, Alex Makhnin, Khadeja A Moses, et al.Pageof 37